Tsioufis Costas, Dimitriadis Kyriakos, Taxiarchou Efstathios, Vasiliadou Carmen, Chartzoulakis George, Tousoulis Dimitrios, Manolis Athanasios, Stefanadis Christodoulos, Kallikazaros Ioannis
Department of Cardiology, Hippokration Hospital, Athens, Greece.
Am J Hypertens. 2006 May;19(5):462-6. doi: 10.1016/j.amjhyper.2005.07.026.
Microalbuminuria (MA) and low-grade inflammation constitute emerging markers of subclinical atherosclerosis. We investigated whether urinary albumin excretion, expressed as the albumin-to-creatinine ratio (ACR), is associated with high sensitivity C-reactive protein (hs-CRP), interleukin (IL)-18, and soluble CD40 ligand (sCD40L), in hypertensive subjects.
The study population consisted of 108 nondiabetic male patients with newly diagnosed untreated stage I to II essential hypertension (aged 44.6 years, office blood pressure [BP] 148/95 mm Hg). According to ACR values determined as the average of two nonconsecutive overnight spot urine samples, subjects were divided into microalbuminurics (n = 28) (mean ACR = 30 to 300 mg/g) and normoalbuminurics (n = 80) (mean ACR <30 mg/g).
Although microalbuminurics as compared to normoalbuminuric hypertensives had greater hs-CRP levels (2.55 +/- 1.18 v 1.45 +/- 0.52 mg/L, P < .0001), independently of confounding factors, these two groups did not differ regarding IL-18 and sCD40L values (P = not significant [NS] for both cases). In the entire population, ACR exhibited a positive correlation with hs-CRP (r = 0.623, P < .0001), whereas there was no association with both IL-18 and sCD40L (P = NS for both cases). When multiple linear regression analysis was performed, it was revealed that age, body mass index, office systolic BP, total cholesterol, and hs-CRP levels were significant independent predictors of the ACR (P < .05).
In essential hypertensive subjects, MA is accompanied by elevated hs-CRP levels, but not by augmented IL-18 and sCD40L concentrations, suggesting activation of different inflammatory pathways in the progression of renal and cardiovascular atherosclerotic disease. The pathophysiologic mechanisms of these associations remain to be further elucidated in future studies.
微量白蛋白尿(MA)和低度炎症是亚临床动脉粥样硬化的新兴标志物。我们研究了以白蛋白与肌酐比值(ACR)表示的尿白蛋白排泄量是否与高血压患者的高敏C反应蛋白(hs-CRP)、白细胞介素(IL)-18和可溶性CD40配体(sCD40L)相关。
研究人群包括108例新诊断的未经治疗的I至II期原发性高血压非糖尿病男性患者(年龄44.6岁,诊室血压[BP]148/95mmHg)。根据作为两个非连续夜间随机尿样平均值测定的ACR值,将受试者分为微量白蛋白尿组(n = 28)(平均ACR = 30至300mg/g)和正常白蛋白尿组(n = 80)(平均ACR <30mg/g)。
尽管与正常白蛋白尿高血压患者相比,微量白蛋白尿患者的hs-CRP水平更高(2.55±1.18对1.45±0.52mg/L,P <.0001),但独立于混杂因素,这两组在IL-18和sCD40L值方面没有差异(两种情况P均为无显著性差异[NS])。在整个人群中,ACR与hs-CRP呈正相关(r = 0.623,P <.0001),而与IL-18和sCD40L均无关联(两种情况P均为NS)。进行多元线性回归分析时,发现年龄、体重指数、诊室收缩压、总胆固醇和hs-CRP水平是ACR的显著独立预测因素(P <.05)。
在原发性高血压患者中,MA伴有hs-CRP水平升高,但不伴有IL-18和sCD40L浓度升高,提示在肾和心血管动脉粥样硬化疾病进展中不同炎症途径的激活。这些关联的病理生理机制有待未来研究进一步阐明。